Sabra Health Care REIT (NASDAQ:SBRA) Given New $13.00 Price Target at Barclays
April 26, 2023
Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) had its price objective reduced by Barclays from $15.00 to $13.00 in a research note released on Tuesday morning, The Fly reports.
Several other research firms have also commented on SBRA. StockNews.com began coverage on shares of Sabra Health Care REIT in a research report on Thursday, March 16th. They set a hold rating for the company. Citigroup decreased their target price on shares of Sabra Health Care REIT from $13.00 to $10.50 and set a neutral rating for the company in a research report on Tuesday, March 28th. Wells Fargo & Company initiated coverage on shares of Sabra Health Care REIT in a research note on Wednesday, April 19th. They set an underweight rating and a $11.00 price objective for the company. Credit Suisse Group reaffirmed a neutral rating and set a $13.00 price objective on shares of Sabra Health Care REIT in a research note on Wednesday, April 12th. Finally, Truist Financial dropped their target price on Sabra Health Care REIT from $14.00 to $13.00 and set a buy rating on the stock in a report on Wednesday, March 29th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of Hold and a consensus price target of $13.10.
Sabra Health Care REIT Stock Down 1.0 %
SBRA stock opened at $10.89 on Tuesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 3.27 and a quick ratio of 3.27. Sabra Health Care REIT has a 1-year low of $10.08 and a 1-year high of $16.60. The firm has a fifty day moving average price of $11.54 and a two-hundred day moving average price of $12.41. The firm has a market cap of $2.52 billion, a price-to-earnings ratio of -32.03 and a beta of 1.31.
Sabra Health Care REIT Announces Dividends
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 28th. Shareholders of record on Monday, February 13th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 10th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 11.02%. Sabra Health Care REIT’s payout ratio is presently -352.93%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Accel Wealth Management bought a new position in shares of Sabra Health Care REIT during the fourth quarter valued at $25,000. EverSource Wealth Advisors LLC bought a new position in shares of Sabra Health Care REIT in the third quarter valued at about $29,000. Point72 Hong Kong Ltd bought a new position in shares of Sabra Health Care REIT in the second quarter valued at about $31,000. Newbridge Financial Services Group Inc. raised its holdings in shares of Sabra Health Care REIT by 64.9% in the first quarter. Newbridge Financial Services Group Inc. now owns 2,308 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 908 shares during the last quarter. Finally, Hollencrest Capital Management bought a new position in shares of Sabra Health Care REIT in the fourth quarter valued at about $31,000. 87.20% of the stock is owned by institutional investors.
About Sabra Health Care REIT
(Get Rating)
Sabra Health Care REIT, Inc is engaged in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Featured Articles
Receive News & Ratings for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s FREE daily email newsletter.